Registered Kenya · PPB

BENZYLBENZOATE

BENZYLBENZOATE

H98/257 25% GENERIC/BIOSIMILARS

What it does

Benzylbenzoate is a topical treatment used to help eliminate certain skin infections caused by parasites.

Commonly used for: scabies, lice infestation

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
H98/257
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
BENZYLBENZOATE
Dosage form
25%
Strength
-
Pack size
60ML AND 100ML
Therapeutic class
GENERIC/BIOSIMILARS
Manufacturer / MAH
Dinlas Pharma
Applicant / LTR
DINLAS PHARMA EPZ LIMITED
Country of origin
LOCAL
Manufacturer location
syokimau off Mombasa road, on Ellen, Park Road, Nairobi, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 20:18:59 · updated 2026-08-03 04:19:21

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Benzylbenzoate is a topical treatment used to help eliminate certain skin infections caused by parasites.

What it treats

  • scabies
  • lice infestation

How it works

It works by killing the mites and lice that cause these infections.

Who it's for

It is suitable for adults and children over a certain age, as directed by a healthcare provider.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: Benzylbenzoate

BNF-referenced

Benzyl benzoate is a topical medication primarily used for the treatment of scabies and lice infestations. It exhibits insecticidal properties by acting on the nervous system of parasites, leading to their death. Although effective, its irritant nature limits its use as the first-line treatment, especially in sensitive populations such as children.

Indications

  • Scabies
  • Lice infestations (head and body)

Dosage

Children: For children, apply 2–3 times a day, continuing for 7 days.

Adults: Apply over the whole body; repeat without bathing on the following day and wash off 24 hours later. A third application may be required in some cases.

Mechanism of action

Benzyl benzoate exerts toxic effects on the nervous system of the parasite, resulting in its death. It is also toxic to mite ova. In vitro studies show that benzyl benzoate can kill the Sarcoptes mite within 5 minutes.

Pharmacodynamics

Benzyl benzoate is recognized as one of the older preparations for treating scabies, a skin infection caused by the mite Sarcoptes scabiei. The condition is characterized by intense itching, particularly at night, and red spots, which may lead to secondary infections. Benzyl benzoate is lethal to the Sarcoptes mite and is also effective against lice infestations. However, due to its irritant properties, it is not considered the treatment of choice for scabies.

Pharmacokinetics

Benzyl benzoate is absorbed through the skin upon topical application, with systemic absorption being minimal. Its pharmacokinetics can vary based on the formulation and the area of application. The drug is metabolized in the body and excreted primarily through urine. Due to its irritant potential, caution is advised when applying to large areas of skin.

Adverse effects

  • Eye irritation
  • Mucosal irritation
  • Skin irritation
  • Hypersensitivity
  • Skin reactions

Precautions

  • Avoid contact with eyes and mucous membranes
  • Should not be applied to broken skin
  • Use caution in sensitive areas such as the head and neck

Pregnancy

Use only if necessary and under medical supervision, as safety during pregnancy has not been established.

Breast-feeding

Suspend feeding until the product has been washed off.

Storage

Store in a cool, dry place away from light.

Formulations

  • Cream
  • Ointment
  • Liquid
BNF 85 (British National Formulary) p.1374 PubChem / pathway

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: Benzylbenzoate

PubChem CID 2345

Molecular formula: C14H12O2

Mechanism of action

Benzyl benzoate exerts toxic effects on the nervous system of the parasite, resulting in its death. It is also toxic to mite ova, though its exact mechanism of action is unknown. In vitro, benzyl benzoate has been found to kill the Sarcoptes mite within 5 minutes.

Pharmacodynamics

Benzyl benzoate is one of the older preparations used to treat scabies. Scabies is a skin infection caused by the mite sarcoptes scabiei. It is characterised by severe itching (particularly at night), red spots, and may lead to a secondary infection. Benzyl benzoate is lethal to this mite and so is useful in the treatment of scabies. It is also used to treat lice infestation of the head and body. Benzyl benzoate is not the treatment of choice for scabies due to its irritant properties.

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.